Skip to main content

Humana stock price and financials

  • HUM · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$450.00+1.42%Close 13 Nov 2026
Market value
$54.77B
P/E
43.96
EV / EBITDA
13.72
Dividend yield
0.8%
Beta · 1 year
0.55
Return · 1 year
+87.1%
52-week range$163.11 — $456.50

Share price close 16 Nov 2026

+5.7%1 monthHigh $456.65Low $410.41
$400$420$440$460Q3 FY2026 report filed 6 Nov 202623 Oct29 Oct4 Nov10 Nov16 Nov
+49.7%6 monthsHigh $456.65Low $301.69
$300$350$400$450$500Q2 FY2026 report filed 29 Jul 2026Q3 FY2026 report filed 6 Nov 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+78.3%year to dateHigh $456.65Low $163.67
$100$200$300$400$500Q4 FY2025 report filed 19 Feb 2026Q1 FY2026 report filed 29 Apr 2026Q2 FY2026 report filed 29 Jul 2026Q3 FY2026 report filed 6 Nov 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+92.6%1 yearHigh $456.65Low $163.67
$100$200$300$400$500Q4 FY2025 report filed 19 Feb 2026Q1 FY2026 report filed 29 Apr 2026Q2 FY2026 report filed 29 Jul 2026Q3 FY2026 report filed 6 Nov 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
−9.9%3 yearsHigh $518.26Low $163.67
$100$200$300$400$500$600Q4 FY2023 report filed 15 Feb 2024Q1 FY2024 report filed 24 Apr 2024Q2 FY2024 report filed 31 Jul 2024Q3 FY2024 report filed 30 Oct 2024Q4 FY2024 report filed 20 Feb 2025Q1 FY2025 report filed 30 Apr 2025Q2 FY2025 report filed 30 Jul 2025Q3 FY2025 report filed 5 Nov 2025Q4 FY2025 report filed 19 Feb 2026Q1 FY2026 report filed 29 Apr 2026Q2 FY2026 report filed 29 Jul 2026Q3 FY2026 report filed 6 Nov 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+128%10 yearsHigh $554.83Low $163.67
$100$200$300$400$500$600Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

Humana reported revenue of $129.7 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 10.1% from fiscal 2024. Net income was $1.19 billion and diluted earnings per share $9.84.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 30 Sep 2026), revenue was $41.2 billion, up 26.1% from a year earlier.

Figures from Humana's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 6 Nov 2026.

Against Health Care

Growth
Upper half
Revenue +10.9% a year over five years · 12th of 37
Profitability
Upper half
Return on invested capital 14.1%, five-year average · 11th of 38
Balance sheet
Top 10%
More cash than debt · 3rd of 38
Valuation
Above the median
P/E 44.0 · 26th of 36

Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.

Revenue FY2025
$129.7B+10.1%
Net income
$1.19B−1.6%
Diluted EPS
$9.84−1.4%
Operating margin
2.1%−0.1 pts
Free cash flow
$375.0M−84.3%
Net cash
$6.99B

Fiscal 2025 against fiscal 2024; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.

Revenue and net income fiscal 2016–2025

  • Revenue
  • Net income
$0$50B$100B$150BRevenue, FY16: $54.38BNet income, FY16: $614MFY16Revenue, FY17: $53.77BNet income, FY17: $2.45BFY17Revenue, FY18: $56.91BNet income, FY18: $1.68BFY18Revenue, FY19: $64.89BNet income, FY19: $2.71BFY19Revenue, FY20: $77.16BNet income, FY20: $3.37BFY20Revenue, FY21: $83.06BNet income, FY21: $2.93BFY21Revenue, FY22: $92.87BNet income, FY22: $2.81BFY22Revenue, FY23: $106.37BNet income, FY23: $2.49BFY23Revenue, FY24: $117.76BNet income, FY24: $1.21BFY24Revenue, FY25: $129.66BNet income, FY25: $1.19BFY25

Margins fiscal 2016–2025

  • Operating
  • Net
0%5%10%2.1%0.9%FY16FY19FY22FY25

Latest quarter · Q3 FY2026 to 30 Sep 2026, filed 6 Nov 2026 · Full results →

Revenue
$41.16B+26.1% on a year
Operating income
$75.00M−81.3% on a year
Net income
$162.0M−16.9% on a year
Diluted EPS
$1.33−17.9% on a year
Free cash flow
$2.03B+142% on a year

Comparable companies All of Health Care →

Humana beside the other S&P 500 members in Managed Health Care, then the largest in Health Care, by market value.

Humana and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
HumanaHUM$54.77B+1.4%+87.1%+22.0%0.8%44.0
Elevance HealthELV$95.73B0.0%+31.2%+3.6%2.5%18.6
Centene CorporationCNC$37.04B+1.4%+96.9%+9.7%0.7%25.4
UnitedHealth GroupUNH—+0.6%+20.2%———
Eli LillyLLY$1.37T+1.1%+41.8%+45.5%31.9%49.6
Johnson & JohnsonJNJ$686.1B+0.8%+47.0%+7.8%16.2%42.6
AbbVieABBV$525.9B+0.2%+26.5%+10.7%15.7%51.1

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Humana revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By product

Humana revenue by product, by fiscal year
RevenueFY 2021FY 2022FY 2023FY 2024FY 2025
External Revenues$82.88B$92.49B+11.6%$105.3B+13.9%$116.5B+10.7%$128.7B+10.4%
Services$3.06B$4.78B+56.3%$4.03B−15.6%$4.43B+9.9%$5.83B+31.6%
Total revenue$83.06B$92.87B$106.4B$117.8B$129.7B

Financial statements

Fiscal years, the latest ending 31 Dec 2025. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

Humana income statement, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$54.38B$53.77B$56.91B$64.89B$77.16B$83.06B$92.87B$106.4B$117.8B$129.7B
Revenue growth+0.2%−1.1%+5.8%+14.0%+18.9%+7.7%+11.8%+14.5%+10.7%+10.1%
Operating income$1.74B$4.26B$3.10B$3.19B$4.99B$3.15B$3.80B$4.01B$2.56B$2.70B
Net income$614.0M$2.45B$1.68B$2.71B$3.37B$2.93B$2.81B$2.49B$1.21B$1.19B
Diluted EPS$4.07$16.81$12.16$20.10$25.31$22.67$22.08$20.00$9.98$9.84
Operating margin3.2%7.9%5.4%4.9%6.5%3.8%4.1%3.8%2.2%2.1%
Net margin1.1%4.6%3.0%4.2%4.4%3.5%3.0%2.3%1.0%0.9%

Cash flow

Humana cash flow, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow$1.94B$4.05B$2.17B$5.28B$5.64B$2.26B$4.59B$3.98B$2.97B$921.0M
Capital expenditure$527.0M$524.0M$612.0M$736.0M$964.0M$1.34B$1.14B$1.00B$575.0M$546.0M
Free cash flow$1.41B$3.53B$1.56B$4.55B$4.67B$920.0M$3.45B$2.98B$2.39B$375.0M

Balance sheet and shares

Humana balance sheet and shares, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$3.88B$4.04B$2.34B$4.05B$4.67B$3.39B$5.06B$4.69B$2.22B$4.20B
Total debt$4.09B$4.92B$6.07B$6.11B$7.14B$13.22B$11.73B$12.25B$12.24B$12.91B
Shareholders' equity$10.69B$9.84B$10.16B$12.04B$13.73B$16.08B$15.31B$16.26B$16.38B$17.66B
Diluted shares151M146M138M135M133M129M127M124M121M121M
Dividends per share$1.16$1.49$1.90$2.15$2.43$2.73$3.06$3.44$3.54$3.54

Quarterly figures

The last eight fiscal quarters, the latest ending 30 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

Humana quarterly financial figures
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$29.21B$32.11B$32.39B$32.65B$32.52B$39.65B$40.87B$41.16B
Revenue, year on year+10.4%+8.4%+9.6%+11.1%+11.3%+23.5%+26.2%+26.1%
Operating income−$543.0M$2.01B$1.10B$400.0M−$808.0M$1.75B$1.36B$75.00M
Net income−$693.0M$1.24B$545.0M$195.0M−$796.0M$1.19B$694.0M$162.0M
Diluted EPS−$5.74$10.30$4.51$1.62−$6.58$9.83$5.73$1.33
Free cash flow−$682.0M$236.0M$1.16B$836.0M−$1.85B$1.13B$1.83B$2.03B

Operating KPIs

The operating figures Humana reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

Humana operating KPIs
KPILatestPeriodChange on a yearRecent periods
Premiums and services revenue detail (State-based contracts and other · Insurance)3,641quarter to 30 Sep 2026down 2.4%
Home Solutions episodic admissions85,650quarter to 31 Mar 2026up 4.3%
PPO/PFFS individual medicare advantage membership3,237.0at 30 Sep 2026up 23.9%
CenterWell, Pharmacy solutions premiums and services revenue detail$3,793quarter to 30 Jun 2026up 21.0%
CenterWell, Primary care premiums and services revenue detail$2,008quarter to 30 Jun 2026up 35.8%
CenterWell, Home solutions premiums and services revenue detail$989quarter to 30 Jun 2026up 7.2%
CenterWell premiums and services revenue detail$6,790quarter to 30 Jun 2026up 22.6%
Mail-Order penetration (Pharmacy Solutions, Total Medicare)23.8%quarter to 31 Mar 2026down 2.2 points
External Revenues$40.8Bquarter to 30 Sep 2026up 26.4%
Services revenue$2.1Bquarter to 30 Sep 2026up 32.8%
Insurance revenue$39.1Bquarter to 30 Sep 2026up 25.3%
CenterWell revenue$7.2Bquarter to 30 Sep 2026up 21.7%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was Humana's revenue in fiscal 2025?

$129.7 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), as reported in its annual report.

What was Humana's net income in fiscal 2025?

$1.19 billion for fiscal year 2025 (the twelve months to 31 Dec 2025).

What were Humana's diluted earnings per share in fiscal 2025?

$9.84 for fiscal year 2025 (the twelve months to 31 Dec 2025).

What is Humana's operating margin?

2.1% for fiscal year 2025 (the twelve months to 31 Dec 2025): operating income divided by revenue.

How much free cash flow did Humana generate in fiscal 2025?

$375 million for fiscal year 2025 (the twelve months to 31 Dec 2025): operating cash flow less capital expenditure.

In the terminal

Twenty years of Humana's figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans